Found 4 matching trials
A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma PHASE3 The purpose of this study is to evaluate the efficacy and safety of SCTB35 ...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma PHASE3 The purpose of this study is to evaluate the efficacy and safety of SCTB35 ...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma PHASE1 This is a Phase I clinical study designed to evaluate the safety, tolerabil...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
A Study of SCTB35 in Patients with Systemic Lupus Erythematosus PHASE1 This study is a multicenter Phase Ib/II clinical trial aimed at evaluating ...
Show More Location
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial